ADHD Treatment Reduces the Risk of Suicidal Behavior

• Research has shown a reduction in the risk of suicidal behavior and criminality when treating ADHD.
• Medications can reduce impulsivity and improve concentration.
• Access issues to ADHD treatment remain relevant in many countries.

Research conducted on the basis of medical records of nearly 150,000 individuals in Sweden showed that medication for ADHD (Attention Deficit Hyperactivity Disorder) is associated with a significant reduction in the risk of suicidal behavior, substance abuse, traffic accidents, and criminality.

The results of the research, published in the British Medical Journal, confirm that ADHD treatment can have significant benefits, including improvements in core symptoms. Specifically, there was a recorded 17% reduction in the risk of suicidal behavior, 15% in substance abuse, 12% in traffic accidents, and 13% in criminality.

Researchers, including Professor Samuel Cortese from the University of Southampton, noted that medications can reduce impulsive behavior and improve concentration, which, in turn, may lower the risk of accidents and aggressive behavior.

The study involved 148,581 individuals aged six to 64 years, among whom ADHD was diagnosed for the first time. Of these, 57% began medication treatment, primarily with methylphenidate, which was initiated in 88% of cases.

Although the research is not randomized, it utilizes a strong criterion for inclusion and statistical methods to compensate for the absence of a randomized distribution of participants in the treatment and placebo groups. This allows researchers to obtain more reliable data on the effectiveness of medications.

Currently, researchers emphasize that access to ADHD treatment in many countries is complicated, and in Great Britain, waiting for a consultation with specialists can take several years.

The results of the research underscore the importance of ADHD treatment for reducing risks associated with this disorder, and can help patients make decisions about starting medication therapy.

Tags: Well-being/Research